4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS

Lower Airway, Pulmonary Parenchymal & Vascular Emergencies

Critical Care Reality: Lower airway and pulmonary parenchymal disorders impair the alveolar-capillary membrane, creating severe ventilation-perfusion ($V/Q$) mismatch, intrapulmonary shunting, and diffusion impairment. Veterinary critical care nurses must distinguish between dynamic bronchospasm, alveolar hemorrhage, bacterial consolidation, high-permeability edema, and cardiogenic congestion to deliver targeted interventions.

---

1. Feline Asthma & Bronchitis Crisis

Feline asthma is an allergic, Type I IgE-mediated hypersensitivity disorder of the lower airways characterized by chronic eosinophilic airway inflammation, bronchial smooth muscle hypertrophy, mucosal edema, and mucus hypersecretion.

[Allergen Exposure / IgE Activation]
                 │
                 ▼
[Mast Cell & Eosinophil Degranulation]
                 │
  ┌──────────────┴──────────────┐
  ▼                             ▼
Bronchial Smooth           Airway Edema &
Muscle Spasm               Mucus Plugging
  └──────────────┬──────────────┘
                 ▼
 [Expiratory Airflow Limitation & Air Trapping]
                 ▼
 [Severe Expiratory Push, Wheezes & Hypoxemia]

Clinical Presentation

• Breathing Pattern: Pronounced expiratory dyspnea characterized by a prolonged expiratory phase and an active "abdominal push" (recruitment of abdominal wall muscles to actively force air out past narrowed bronchioles).
• Auscultation: Expiratory musical wheezes, crackles, or severely attenuated lung sounds in regions of mucus plugging; open-mouth breathing in cats is a life-threatening sign.
• Stress Sensitivity: Cats in respiratory crisis have zero physiological reserve. The stress of venipuncture, cystocentesis, or forced radiography can cause fatal dynamic airway closure and cardiac arrest. "Oxygen first, hands off, sedate/bronchodilate early."

Emergency Pharmacotherapy for Feline Asthma

1. Beta-2 Adrenergic Receptor Agonists (Rapid Bronchodilation):
   • Inhaled Albuterol (Salbutamol): Delivered via a metered-dose inhaler (MDI) attached to an AeroKat feline aerosol chamber with mask. Deliver 1 to 2 puffs, allowing the cat to take 5 to 10 breaths through the chamber. Onset: 1 to 5 minutes; duration: 2 to 4 hours.
   • Injectable Terbutaline: $0.01\text{ mg/kg SC, IM, or slow IV}$ — Rapidly relaxes bronchial smooth muscle by stimulating adenylate cyclase to increase intracellular cyclic AMP ($cAMP$). Can be repeated in 15–30 minutes if response is incomplete.
2. Glucocorticoids (Anti-Inflammatory):
   • Dexamethasone Sodium Phosphate (Dex SP): $0.1\text{ to }0.2\text{ mg/kg IV or IM}$ — Blunts eosinophil recruitment and downregulates pro-inflammatory cytokine release.
   • Note: Long-term maintenance transitions to inhaled fluticasone propionate (44 mcg or 110 mcg MDI q12h) after emergency stabilization.
3. Supplemental Oxygen: Place in a dedicated, quiet, temperature-controlled oxygen cage ($FiO_2 \approx 40\text{--}50%$).

---

2. Traumatic Pulmonary Contusions

Pulmonary contusions represent traumatic damage to the pulmonary parenchyma resulting from blunt thoracic trauma (e.g., hit-by-car [HBC], falls from height [high-rise syndrome], dog attacks). Blunt impact shears alveolar walls and microvasculature, causing intra-alveolar hemorrhage, interstitial edema, atelectasis, and disruption of pulmonary surfactant.

Clinical Course & The 24–48 Hour Rule

• Delayed Progression: Pulmonary contusions are dynamic and progressively worsen over the first 24 to 48 hours following trauma. Initial thoracic radiographs taken immediately after injury often drastically underestimate the true severity of parenchymal damage.
• Pathophysiology: Blood and proteinaceous exudate flood the alveolar spaces, creating areas of intrapulmonary shunt (alveoli are perfused by pulmonary arterial blood but cannot participate in gas exchange, $V/Q = 0$). This results in severe, refractory hypoxemia.

Resuscitation & Nursing Strategy

• Restrictive / Judicious Fluid Therapy: Excessive IV fluid administration increases pulmonary hydrostatic capillary pressure and washes out oncotic proteins, accelerating alveolar flooding. If the patient is in hypovolemic shock, administer conservative crystalloid aliquots (10–20 mL/kg in dogs, 5–10 mL/kg in cats) or hypertonic saline (7.2% NaCl at 3–4 mL/kg over 5 minutes) combined with synthetic colloids to restore intravascular volume without fluid overloading the damaged lungs.
• Analgesia: Effective multimodal analgesia (pure mu-opioids such as fentanyl CRI 2–5 mcg/kg/hr or methadone 0.2–0.3 mg/kg IV) relieves chest wall pain from concurrent rib fractures, allowing deeper, more effective tidal ventilation.

---

3. Aspiration Pneumonia

Aspiration pneumonia develops when liquid or particulate matter from the gastrointestinal tract (vomitus, regurgitated material) or oropharynx enters the lower respiratory tract. It begins as a sterile chemical pneumonitis caused by acidic gastric secretions and digestive enzymes, followed within 24 to 72 hours by secondary bacterial infection.

Predisposing Risk Factors & Anatomical Distribution

• Risk Factors: Megaesophagus, general anesthesia (especially without a cuffed ET tube), laryngeal paralysis, myasthenia gravis, severe vomiting/regurgitation, altered mentation/seizures.
• Anatomic Distribution: Due to the gravitational orientation and ventral take-off of the bronchus from the trachea, the Right Middle Lung Lobe is most frequently and severely consolidated, followed by the cranial lung lobes.

                    ASPIRATION PNEUMONIA MANAGEMENT

     ┌────────────────────────────────────────────────────────┐
     │ 1. Four-Quadrant Broad-Spectrum Antimicrobials         │
     │    • Ampicillin-Sulbactam (30-50 mg/kg IV q8h)         │
     │    • PLUS Enrofloxacin (10 mg/kg IV q24h) if severe    │
     └──────────────────────────┬─────────────────────────────┘
                                │
     ┌──────────────────────────┴─────────────────────────────┐
     │ 2. Airway Hydration & Clearance                        │
     │    • Saline Nebulization (10-15 min q4-6h)             │
     │    • IMMEDIATE Thoracic Coupage (5-10 min)             │
     │    • Early Patient Mobilization & Recumbency Changes   │
     └──────────────────────────┬─────────────────────────────┘
                                │
     ┌──────────────────────────┴─────────────────────────────┐
     │ 3. Critical Nursing Rules                              │
     │    • NEVER administer cough suppressants (antitussives)│
     │    • Elevate head and thoracic cage 15-30°             │
     └────────────────────────────────────────────────────────┘

Treatment Protocols & Airway Clearance

• Antimicrobial Therapy: Empiric four-quadrant coverage (gram-positive, gram-negative, aerobic, and anaerobic) for severe or septic cases:
  • First-line injectable: Ampicillin-Sulbactam (Unasyn) $30\text{ to }50\text{ mg/kg IV q8h}$.
  • Severe / Sepsis escalation: Add Enrofloxacin ($10\text{ mg/kg IV q24h}$ in dogs) or Marbofloxacin for potent gram-negative enteric coverage.
• Saline Nebulization & Coupage: Administer ultrasonic or jet nebulization using sterile 0.9% saline for 10 to 15 minutes to hydrate desiccated airway secretions. Immediately follow nebulization with thoracic coupage (cupped-hand percussive clapping against both sides of the thoracic wall for 5–10 minutes) to loosen mucus and trigger productive coughing.
• Absolute Contraindication: Do NOT administer antitussives (cough suppressants) like butorphanol, codeine, or hydrocodone; the cough reflex is the patient's primary defense mechanism to evacuate purulent bacteria from the lungs.

---

4. Non-Cardiogenic vs. Cardiogenic Pulmonary Edema

Distinguishing Non-Cardiogenic Pulmonary Edema (NCPE) from Cardiogenic Pulmonary Edema (CPE) is a foundational ECC skill because their pathophysiological mechanisms and therapeutic strategies are polar opposites.

Negative Pressure Pulmonary Edema (NPPE)

Occurs when an animal makes violent inspiratory efforts against a completely occluded upper airway (e.g., severe BOAS, laryngeal paralysis, strangulation). The extreme negative intrathoracic pressure (up to $-40\text{ to }-50\text{ cmH}_2\text{O}$) creates a massive transudative gradient that pulls fluid out of the pulmonary capillaries, while systemic catecholamine surges cause intense vasoconstriction and pulmonary capillary stress failure.

---

5. Acute Respiratory Distress Syndrome (ARDS) in Veterinary Medicine

Acute Respiratory Distress Syndrome (ARDS) represents the catastrophic culmination of acute, diffuse inflammatory lung injury. In veterinary medicine, ARDS is diagnosed using the consensus criteria adapted from the human Berlin definition (established by the Veterinary ARDS Consortium).

The 4 Core Diagnostic Criteria for Vet-ARDS

                     VETERINARY ARDS CONSENSUS CRITERIA

  1. ACUTE ONSET           < 72 Hours from initiating clinical insult
         │
         ▼
  2. KNOWN RISK FACTOR     Sepsis, SIRS, Severe Pancreatitis, Polytrauma,
                           Smoke Inhalation, Massive Transfusion (TRALI)
         │
         ▼
  3. NON-CARDIOGENIC       Diffuse, bilateral pulmonary infiltrates on
     INFILTRATES           radiographs/CT without left atrial enlargement
         │
         ▼
  4. SEVERE HYPOXEMIA      Categorized by PaO2 / FiO2 Ratio:
     (P/F Ratio)           • Acute Lung Injury (ALI): PaO2/FiO2 ≤ 300 mmHg
                           • ARDS: PaO2/FiO2 ≤ 200 mmHg (on PEEP ≥ 5 cmH2O)

Pathophysiological Phases of ARDS

1. Exudative Phase (Days 1–3): Severe endothelial and alveolar epithelial cell death, breakdown of the blood-air barrier, loss of surfactant, alveolar flooding with dense proteinaceous fluid, and formation of hyaline membranes.
2. Proliferative Phase (Days 4–7): Type II pneumocyte proliferation and infiltration of myofibroblasts attempting to repair the alveolar matrix.
3. Fibrotic Phase (Day 7+): Extensive collagen deposition, irreversible pulmonary fibrosis, architectural obliteration, and chronic ventilatory dependence.

Clinical Management of ARDS

• ARDS carries an extremely grave prognosis in dogs and cats ($>80\text{--}90%$ mortality).
• Medical therapy alone is virtually universally fatal; the only supportive therapy capable of sustaining life is Positive Pressure Mechanical Ventilation (PPMV) utilizing lung-protective strategies (low tidal volume 6–8 mL/kg, high PEEP 5–10 cmH2O, permissive hypercapnia) while aggressively addressing the underlying trigger (e.g., source control for septic peritonitis or treatment of severe pancreatitis).